Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nora Volkow

Strong Weed Is No Reason for Prohibition

New research on cannabis use could reshape the debate around marijuana legalization and revive old arguments for restricting legal markets.

Reason

3 Disasters That Legal Weed Didn't Unleash—Despite the Forecasts

From higher crime to teenage stoners, here are things that the weed debate got wrong.

Reason

The hidden victims of the opioid crisis: the ones who lived

After overdoses left them with brain injuries and lasting complications, Americans are struggling to get proper care. Experts call it another epidemic

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump administration is pushing for psychedelic therapy. Will it help or hamper the field?

US health secretary Robert F Kennedy Jr said he wants psychedelic therapies approved within a year, surprising even the staunchest supporters of the drugs.

Euronews

Will RFK Jr.'s push for psychedelic therapy help or hamper the emerging field?

Health Secretary Robert F

The Independent UK

How Making GLP-1s Available Over the Counter Can Unlock Their Full Potential

Drugs like Ozempic might not only address obesity but also alcoholism, smoking, and drug addiction.

Reason

Can Ozempic help us fight addiction?

Surprising research strongly suggests semaglutide can help fight substance use disorder. Why aren't we using it?

Salon

Read news from The Economist, FT, and more,
with one subscription

Overdoses decline but not for everyone

The country is still losing more than 100,000 people to drug overdoses every year, with stark racial disparities

Salon

A Study of 'Problematic' Opioid Use Among Pain Patients Is Less Alarming Than It Seems

The authors of the meta-analysis misleadingly imply that pain treatment should be blamed for recent increases in drug-related deaths.

Reason

Americans have demonized drugs for decades. Now we’re doing them every day

Regular drug use – from caffeine to psychedelics – has become a fundamental part of modern life. A first-person Guardian US series explores America’s shifting relationship with mind-altering substances

The Guardian - US

As 'magic mushrooms' got more attention, drug busts of the psychedelic drug went up

Busts of psilocybin mushrooms went way up from 2017 to 2022, a new study finds, even as the psychedelic drug's potential benefits have been explored by scientists.

WEKU

'Just say no' didn't actually protect students from drugs. Here's what could

For years, programs like D.A.R.E. told students to "just say no" to drugs. But research shows that approach alone didn't work. Now experts are backing a new approach that could help save lives.

WEKU

Overdose deaths involving street xylazine surged years earlier than reported

A new report from the Centers for Disease Control and Prevention found U.S. deaths involving xylazine, known on the street as Tranq, had already risen 35-fold by 2021.

WEKU

A deadly new street drug caught the U.S. off guard. Experts say it'll happen again

A dangerous chemical called xylazine is being mixed into fentanyl across the U.S., but who's doing it and why is a mystery. The government still doesn't identify and track new drug threats.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Is "pre-addiction" really a thing?

"I don't know if this is a helpful term": experts torn on a concept invented to help treat drug addiction

The Independent UK

Cannabis addiction appears to have ‘serious’ long-term effect in young men

‘Study adds to growing understanding that cannabis use is not harmless’

Tribune News Service

Biden ponders marijuana moves as states forge ahead

WASHINGTON — Five states will vote next week on whether to join the 21 states and territories that have legalized recreational marijuana for adults. But the federal government is still stuck on whether to remove the plant from Schedule I of the federal drug code — a category reserved for…

Roll Call

Biden ponders marijuana moves as states forge ahead - Roll Call

The U.S. policy debate has focused on whether more research is needed on potential benefits and harms of marijuana.

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

"Tranq dope" spreads to more cities

Xylazine is contaminating the drug supply, causing grisly injuries and death

Benzinga

NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development

This week, an annual drug use survey Monitoring the Future (MTF), conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor

Benzinga

Psychedelics And The National Institutes Of Health—How Do They Relate?

As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedel

Benzinga

CDC: Alcohol & Cannabis Most Common Substances For Which People Seek Treatment In Times Of Mental Health Crises

The Centers for Disease Control and Prevention (CDC) recently released its Morbidity and Mortality Weekly Report revealing that the most common substances for which adult Americans have sought substance misuse treatment in 2019 were alcohol, cannabis, and a combina

Benzinga

Occasional Cannabis Use Doesn't Impair Physical Health Of Young Adults, Twin Study Confirms

How does occasional cannabis use affect our health? A frequent question, for which there is no simple and conclusive answer. The impact on our overall physical and mental health has yet to be fully researched. The federal status of cannabis as a Schedule I drug severely limits scientific studies on this…

Benzinga

DEA Delays Medical Marijuana Clinical Trials Yet Illicit Market Continues To Thrive

As states legalize marijuana, some as long as 10 years ago, many are beginning to realize the public health and safety implications of a variety of new high-potency products

WEKU

Overdose deaths continued to rise in 2021, reaching historic highs

New numbers from the Centers for Disease Control and Prevented show that synthetic opioid use is still driving the overdose crisis in the U.S.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.